Oc-0135 Can Patient Reported Outcome Measures Replace Clinical Assessments in Breast Radiotherapy Trials?

Haviland, J.S.; Sydenham, M.; Mills, Judith; Hopwood, Penelope; Bliss, J; Yarnold, J.

doi:10.1016/s0167-8140(12)70474-7

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Limitations Of the Study1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2014

2018

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most have suggested that patients rate their treatment toxicity outcome more positively as compared with clinicians. Conversely, the large multi-centre START trial suggested that patients score their treatment toxicity more severely as compared with clinicians [14].…”

Section: Discussionmentioning

confidence: 99%

“…Despite this, PROMs may still be very useful in detecting differences between treatment arms, as illustrated in the START trial. Haviland et al [14] showed that PROMs are sensitive enough to distinguish changes in normal tissue toxicity between different whole breast radiotherapy fractionation arms. By comparison, PROMs did not show a significant reduction in normal tissue toxicity due to IMRT in the Cambridge breast IMRT trial.…”

Section: Limitations Of the Studymentioning

confidence: 99%

See 1 more Smart Citation